{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T05:13:53Z","timestamp":1741151633418,"version":"3.38.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,3]]},"DOI":"10.7759\/cureus.79997","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T04:49:01Z","timestamp":1741063741000},"source":"Crossref","is-referenced-by-count":0,"title":["Miller Fisher Syndrome as a Stroke Mimic: A Case Report"],"prefix":"10.7759","author":[{"given":"Anmol","family":"Multani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A","family":"Leon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorlelei","family":"Lee-Haynes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward J","family":"Durant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2023.10.036","article-title":"High risk and low prevalence diseases: Guillain-Barr\u00e9 syndrome","volume":"75","author":"Madden J","year":"2024","unstructured":"Madden J, Spadaro A, Koyfman A, Long B. High risk and low prevalence diseases: Guillain-Barr\u00e9 syndrome. Am J Emerg Med. 2024, 75:90-7. 10.1016\/j.ajem.2023.10.036","journal-title":"Am J Emerg Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00517-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"397","author":"Shahrizaila N","year":"2021","unstructured":"Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barr\u00e9 syndrome. Lancet. 2021, 397:1214-28. 10.1016\/S0140-6736(21)00517-1","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000001086","article-title":"Guillain-Barr\u00e9 syndrome in an era of global infections and 21st century vaccination","volume":"35","author":"Lunn MP","year":"2022","unstructured":"Lunn MP. Guillain-Barr\u00e9 syndrome in an era of global infections and 21st century vaccination. Curr Opin Neurol. 2022, 35:571-8. 10.1097\/WCO.0000000000001086","journal-title":"Curr Opin Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/WNO.0b013e3181c2514b","article-title":"The Fisher variant of Guillain-Barr\u00e9 syndrome (Fisher syndrome)","volume":"29","author":"Snyder LA","year":"2009","unstructured":"Snyder LA, Rismondo V, Miller NR. The Fisher variant of Guillain-Barr\u00e9 syndrome (Fisher syndrome). J Neuroophthalmol. 2009, 29:312-24. 10.1097\/WNO.0b013e3181c2514b","journal-title":"J Neuroophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.35656","article-title":"Miller Fisher syndrome associated with COVID-19: a child case report and an up-to-date review of the literature","volume":"15","author":"Poyraz T","year":"2023","unstructured":"Poyraz T. Miller Fisher syndrome associated with COVID-19: a child case report and an up-to-date review of the literature. Cureus. 2023, 15:e35656. 10.7759\/cureus.35656","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-302824","article-title":"Bickerstaff brainstem encephalitis and Fisher syndrome: anti-GQ1b antibody syndrome","volume":"84","author":"Shahrizaila N","year":"2013","unstructured":"Shahrizaila N, Yuki N. Bickerstaff brainstem encephalitis and Fisher syndrome: anti-GQ1b antibody syndrome. J Neurol Neurosurg Psychiatry. 2013, 84:576-83. 10.1136\/jnnp-2012-302824","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.26192","article-title":"Recurrent Miller Fisher syndrome","volume":"14","author":"Ooi ST","year":"2022","unstructured":"Ooi ST, Ahmad A, Yaakub A. Recurrent Miller Fisher syndrome. Cureus. 2022, 14:e26192. 10.7759\/cureus.26192","journal-title":"Cureus"},{"key":"ref8","article-title":"Miller Fisher syndrome: a case report highlighting heterogeneity of clinical features and focused differential diagnosis","volume":"75","author":"Yepishin IV","year":"2016","unstructured":"Yepishin IV, Allison RZ, Kaminskas DA, Zagorski NM, Liow KK. Miller Fisher syndrome: a case report highlighting heterogeneity of clinical features and focused differential diagnosis. Hawaii J Med Public Health. 2016, 75:196-9.","journal-title":"Hawaii J Med Public Health"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70215-1","article-title":"Clinical features, pathogenesis, and treatment of Guillain-Barr\u00e9 syndrome","volume":"7","author":"van Doorn PA","year":"2008","unstructured":"van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barr\u00e9 syndrome. Lancet Neurol. 2008, 7:939-50. 10.1016\/S1474-4422(08)70215-1","journal-title":"Lancet Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120179","article-title":"Reasons for delayed treatment initiation in Guillain-Barre syndrome","volume":"434","author":"Kenan G","year":"2022","unstructured":"Kenan G, Regev T, Kushnir M, Cohen O, Gandelman-Marton R, Kimiagar I, Armon C. Reasons for delayed treatment initiation in Guillain-Barre syndrome. J Neurol Sci. 2022, 434:120179. 10.1016\/j.jns.2022.120179","journal-title":"J Neurol Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v10.i6.1896","article-title":"Asymmetric limb weakness in Guillain-Barr\u00e9 syndrome: three case reports","volume":"10","author":"Hu M","year":"2022","unstructured":"Hu M, Li X, Wong HY, Feng XG, Wang YZ, Zhang GR. Asymmetric limb weakness in Guillain-Barr\u00e9 syndrome: three case reports. World J Clin Cases. 2022, 10:1896-902. 10.12998\/wjcc.v10.i6.1896","journal-title":"World J Clin Cases"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24772","article-title":"Factors contributing to delay in diagnosis of Guillain-Barr\u00e9 syndrome and impact on clinical outcome","volume":"53","author":"Dubey D","year":"2016","unstructured":"Dubey D, Kapotic M, Freeman M, Sawhney A, Rojas JC, Warnack W, Vernino S. Factors contributing to delay in diagnosis of Guillain-Barr\u00e9 syndrome and impact on clinical outcome. Muscle Nerve. 2016, 53:384-7. 10.1002\/mus.24772","journal-title":"Muscle Nerve"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.684847","article-title":"Disease and patient characteristics contributing to diagnostic delays in patients with Guillain-Barr\u00e9 syndrome","volume":"12","author":"Pathikonda C","year":"2021","unstructured":"Pathikonda C, Katyal N, Narula N, Govindarajan R. Disease and patient characteristics contributing to diagnostic delays in patients with Guillain-Barr\u00e9 syndrome. Front Neurol. 2021, 12:684847. 10.3389\/fneur.2021.684847","journal-title":"Front Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-009-5254-8","article-title":"A Guillain-Barr\u00e9 syndrome variant with prominent facial diplegia","volume":"256","author":"Susuki K","year":"2009","unstructured":"Susuki K, Koga M, Hirata K, Isogai E, Yuki N. A Guillain-Barr\u00e9 syndrome variant with prominent facial diplegia. J Neurol. 2009, 256:1899-905. 10.1007\/s00415-009-5254-8","journal-title":"J Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002256","article-title":"Acute bulbar palsy as a variant of Guillain-Barr\u00e9 syndrome","volume":"86","author":"Kim JK","year":"2016","unstructured":"Kim JK, Kim BJ, Shin HY, et al.. Acute bulbar palsy as a variant of Guillain-Barr\u00e9 syndrome. Neurology. 2016, 86:742-7. 10.1212\/WNL.0000000000002256","journal-title":"Neurology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/mus.25242","article-title":"Paraparetic Guillain\u2010Barr\u00e9 syndrome: nondemyelinating reversible conduction failure restricted to the lower limbs","volume":"55","author":"Kimachi T","year":"2017","unstructured":"Kimachi T, Yuki N, Kokubun N, Yamaguchi S, Wakerley BR. Paraparetic Guillain\u2010Barr\u00e9 syndrome: nondemyelinating reversible conduction failure restricted to the lower limbs. Muscle Nerve. 2017, 55:281-5. 10.1002\/mus.25242","journal-title":"Muscle Nerve"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awt285","article-title":"Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria","volume":"137","author":"Fokke C","year":"2014","unstructured":"Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria. Brain. 2014, 137:33-43. 10.1093\/brain\/awt285","journal-title":"Brain"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16365","article-title":"Guillain-Barr\u00e9 syndrome: a comprehensive review","volume":"31","author":"Bellanti R","year":"2024","unstructured":"Bellanti R, Rinaldi S. Guillain-Barr\u00e9 syndrome: a comprehensive review. Eur J Neurol. 2024, 31:e16365. 10.1111\/ene.16365","journal-title":"Eur J Neurol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-022-08210-z","article-title":"Cost-minimisation analysis of plasma exchange versus IVIg in the treatment of autoimmune neurological conditions","volume":"22","author":"Klemencic Kozul T","year":"2022","unstructured":"Klemencic Kozul T, Yudina A, Donovan C, Pinto A, Osman C. Cost-minimisation analysis of plasma exchange versus IVIg in the treatment of autoimmune neurological conditions. BMC Health Serv Res. 2022, 22:904. 10.1186\/s12913-022-08210-z","journal-title":"BMC Health Serv Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/2050312119840195","article-title":"Rescue treatment in patients with poorly responsive Guillain-Barre syndrome","volume":"7","author":"Alboudi AM","year":"2019","unstructured":"Alboudi AM, Sarathchandran P, Geblawi SS, et al.. Rescue treatment in patients with poorly responsive Guillain-Barre syndrome. SAGE Open Med. 2019, 7:2050312119840195. 10.1177\/2050312119840195","journal-title":"SAGE Open Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/268806-miller-fisher-syndrome-as-a-stroke-mimic-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T04:49:02Z","timestamp":1741063742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/268806-miller-fisher-syndrome-as-a-stroke-mimic-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.79997","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,3]]}}}